Anti-Microcystin Antibody Detection in Plasma
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods are inadequate for confirming cyanotoxin exposure in humans, as they primarily detect toxins in water samples and not in biological samples, making it difficult to diagnose exposure after the toxin has cleared from the body.
Innovation Solution
A method that detects anti-Microcystin antibodies in plasma samples using a substrate coated with a protein capable of conjugating with the ADDA region of microcystin, allowing for the detection of antibodies indicative of toxic cyanobacteria exposure, even after the toxin has been cleared.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current diagnostic methods (ELISA, LC-MS) are used to detect cyanotoxins, then toxin levels in water samples can be detected, but these methods cannot detect exposure in biological samples after toxin clearance
Solution Approach 1:
Instead of detecting the toxin directly as current methods do, the invention detects the immune response (antibodies) produced by the host in response to toxin exposure. This inversion allows detection long after the toxin has been cleared from the body, solving the limitation of current methods that can only detect toxins while they are still present in detectable amounts.
Solution Approach 2:
The invention uses antibodies as an intermediary marker to indicate toxin exposure. Rather than directly detecting the toxin, the assay detects the host's immune response (anti-Microcystin antibodies) which serves as a biomarker for exposure, allowing indirect but reliable detection of exposure events that occurred days to months prior.
2Measurement precision
If direct toxin detection methods are used, then acute exposure can be detected, but exposure detection is impossible after biological clearance of the toxin
Solution Approach 1:
The host's immune system performs preliminary action by producing antibodies in response to toxin exposure. These antibodies persist in the body long after the toxin is cleared, creating a detectable marker that extends the detection window from hours/days to potentially months, allowing retrospective diagnosis of exposure events.
Solution Approach 2:
The invention shifts from detecting the toxin itself to detecting the immune response to the toxin. This inversion transforms a time-limited detection problem (toxin clearance) into a time-extended detection capability (antibody persistence), enabling detection long after exposure.
3Reliability
If ELISA and LC-MS methods are applied, then toxin presence in water can be confirmed, but differential diagnosis of cyanotoxin exposure in patients cannot be established
Solution Approach 1:
The invention creates a diagnostic assay that is universally applicable to detecting cyanotoxin exposure in human biological samples. The assay uses anti-Microcystin antibodies that can detect exposure through multiple routes (ingestion, inhalation, skin contact) and can be performed on various biological specimens (blood, serum, plasma), making it broadly useful for clinical differential diagnosis.
Solution Approach 2:
The assay uses antibodies as an intermediary that bridges the gap between toxin exposure and detectable signal. This intermediary approach enables the development of a clinical diagnostic tool that can confirm exposure in patients presenting with symptoms, facilitating differential diagnosis of cyanotoxin-related illnesses.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables effective diagnostic testing for cyanotoxin exposure in biological samples, providing a means for differential diagnosis and epidemiological studies, capable of detecting exposure days to months after initial exposure.
Implementation Method 1
analyzing the sample for the presence antibodies raised in the host
Data Source
AI summary
Methods and kits for the detection of toxic cyanobacteria in a sample by analyzing the sample for the presence antibodies raised in a host, where the presence of antibodies is indicative of toxic cyanobacteria, are described.